- Associated Press - Friday, August 8, 2014

JEFFERSON CITY, Mo. (AP) - Missouri will receive$693,000 part of a $35 million settlement with a Pfizer Inc. subsidiary over the marketing of an organ-transplant drug.

Forty-one states and the District of Columbia reached the deal with the drug maker over charges that Wyeth Pharmaceuticals trained its sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.

Pfizer bought Wyeth in 2009. The company agreed to pay nearly $491 million in July 2013 to resolve a similar investigation by the Department of Justice.

New York-based Pfizer said in a statement the alleged activity occurred before it acquired Wyeth. Pfizer didn’t admit wrongdoing or liability as part of the settlement.


Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide